ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nanoparticle-enabled concurrent modulation of phagocytosis and repolarization of macrophages for enhanced cancer immunotherapy

Zhang, Jing-Yang; Chen, Fang -Man; Liu, Rong; Luo, Jia-Qi; Huang, Yong-Cong; Shu, Na; Zheng, Sui-Juan; Shao, Dan; Leong, Kam W.*; Du, Jin-Zhi*new
Nano Today2022-12DOI: 10.1016/j.nantod.2022.101651
2被引13阅读
引用收藏
分享

摘要

Activating macrophages for cancer immunotherapy has attracted intensive attention in recent years, but faces two major challenges. First, tumor-associated macrophages (TAMs) are predominately pro-tumori-genic M2 phenotype. Second, the phagocytosis of macrophages to cancer cells is severely inhibited by the upregulation of 'don't eat me' signals. In this study, we identified that resiquimod (R848), a small-molecule toll-like receptor 7/8 agonist, could promote the phagocytosis of macrophages while reprogramming macrophages to the anti-tumoral M1 phenotype. This pro-phagocytic effect could be further improved via the combination with anti-SIRP alpha antibody (aSIRP alpha). We then constructed a disulfide-bridged mesoporous silica nanoparticle (MSN)-based delivery system (RMSN-aSIRP alpha) for the co-delivery of R848 and aSIRP alpha to potentiate macrophage-mediated cancer immunotherapy. RMSN-aSIRP alpha was prepared by loading R848 into the cavity, and adsorbing aSIRP alpha on the surface of MSNs. aSIRP alpha interacts with SIRP alpha on macrophages to block the CD47-SIRP alpha axis, and synergized with R848 to promote macrophage phagocytosis. Meanwhile, R848 stimulated M2-to-M1 repolarization of TAMs in the tumor microenvironment (TME). In animal stu-dies with aggressive melanoma and breast cancer models, RMSN-aSIRP alpha significantly improved the anti-tumor efficacy and resulted in immunostimulatory TME by reducing the abundance of M2 macrophages and facilitating tumor infiltration of CD8+ T cells. These findings demonstrate that the nanoparticle-enabled combination of macrophage repolarization and CD47-SIRP alpha blockade can amplify macrophage-based immune response.

学科与关键词

关键词
NanoparticlePhagocytosisRepolarizationMacrophageCancer immunotherapy
相关
加载中…
  • Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy
    Luo, Jia-Qi; Liu, Rong; Chen, Fang-Man; Zhang, Jing-Yang; Zheng, Sui-Juan; Shao, Dan; Du, Jin-Zhi*ACS Nano, 2023, 17(10): 8966-8979.被引 14
  • Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy
    Zhang, Ya-Ru; Luo, Jia-Qi; Zhang, Jing-Yang; Miao, Wei-Min; Wu, Jia-Si; Huang, Hua; Tong, Qi-Song; Shen, Song; Leong, Kam W.; Du, Jin-Zhi*; Wang, JunSmall, 2020, 16(46): 2004240.被引 45
  • A Redox-responsive Prodrug Nanogel of TLR7/8 Agonist for Improved Cancer Immunotherapy
    Wang, Kai-Shuo; Jin, Yu-Feng; Tong, Qi-Song; Huang, Yong-Cong; Gao, Zhen-Lin; Zheng, Sui-Juan; Zhang, Jing-Yang; Wang, Jun*; Du, Jin-Zhi*CHINESE JOURNAL OF POLYMER SCIENCE, 2023, 41(1): 32-39.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Nano Today
发表日期
2022-12
卷期
第 47 卷
页码
101651
DOI
10.1016/j.nantod.2022.101651
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Guangdong Provincial Programs; Guangdong Natural Science Funds for Distinguished Young Scholar; Fundamental Research Funds for Central Universities; [51922043]; [52173122]; [2017GC010304]; [2017A030306018]

作者

  • Z

    Zhang, Jing-Yang (第一作者)

  • C

    Chen, Fang -Man

查看全部 10 位作者收起作者
  • L

    Liu, Rong

  • L

    Luo, Jia-Qi

  • H

    Huang, Yong-Cong

  • S

    Shu, Na

  • Z

    Zheng, Sui-Juan

  • S

    Shao, Dan

  • L

    Leong, Kam W. (通讯)

    new

  • D

    Du, Jin-Zhi (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417